Axcelis Technologies Inc.
Rating
Updated: Aug 24, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Axcelis Technologies, Inc. is a company dedicated to the creation, production, and maintenance of specialized ion implantation and other essential processing machinery used in the fabrication of semic...
Latest News
1 day ago · prnewswire.com
Axcelis Announces Sponsorship and Participation in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026)BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) taking place September 28 - October 2, 2026, at the Pacifico Yokohama North in Japan.
5 days ago · zacks.com
Axcelis Technologies (ACLS) Sees a More Significant Dip Than Broader Market: Some Facts to KnowAxcelis Technologies (ACLS) concluded the recent trading session at $103.75, signifying a -1.23% move from its prior day's close.
6 days ago · zacks.com
ACLS Falls 22.4% in Past Month as Recovery Meets Fresh Margin PressureAxcelis shares fell 22.4% in a month as recovering bookings and demand collide with weaker margins, backlog pressure and heavy China exposure.
6 days ago · zacks.com
ACLS Invests $35M in Korea To Expand Its Manufacturing InfrastructureAxcelis plans a $35M South Korea ion implantation facility to expand Asian capacity as memory, power and mature-node activity improves.
6 days ago · zacks.com
Should Investors Buy ACLS as Growth Returns Despite Premium Valuation?Axcelis growth is returning as memory, power and aftermarket demand improve, but premium valuation and incomplete margin recovery keep execution in focus.
8 days ago · prnewswire.com
Axcelis Announces Sponsorship and Participation in the 25th International Conference on Ion Implantation and Annealing Technology 2026BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the International Conference on Ion Implantation and Annealing Technology 2026 (IIT 2026) taking place September 20-24 at the Congress Center Villach in Austria.
13 days ago · gurufocus.com
Axcelis Technologies Inc (ACLS) Shares Fall 3.0% -- GF Value Says Still OvervaluedOn September 09, 2026, Axcelis Technologies Inc (ACLS) shares fell 3.0%, closing at $115.56. The stock has experienced volatility over the past year, with a 52-
13 days ago · zacks.com
Axcelis Technologies (ACLS) Declines More Than Market: Some Information for InvestorsAxcelis Technologies (ACLS) closed the most recent trading day at $115.56, moving 3.03% from the previous trading session.
14 days ago · prnewswire.com
Axcelis to Build New Manufacturing Facility in Pyeongtaek, KoreaBEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.
21 days ago · prnewswire.com
Axcelis Announces Participation in Upcoming Investor ConferencesBEVERLY, Mass., Sept. 1, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Citi 2026 Global TMT Conference on Tuesday, September 8th at the New York Hilton Midtown.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ACLS